TUMESCENT TECHNIQUE FOR REGIONAL ANESTHESIA PERMITS LIDOCAINE DOSES OF 35 MG/KG FOR LIPOSUCTION

被引:335
作者
KLEIN, JA [1 ]
机构
[1] UNIV CALIF IRVINE, CALIF COLL MED, DEPT DERMATOL, IRVINE, CA 92717 USA
来源
JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY | 1990年 / 16卷 / 03期
关键词
D O I
10.1111/j.1524-4725.1990.tb03961.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Abstract. The tumescent technique for local anesthesia permits regional local anesthesia of the skin and subcutaneous tissues by direct infiltration. The tumescent technique uses large volumes of a dilute anesthetic solution to produce swelling and firmness of targeted areas. This investigation examines the absorption pharmacokinetics of dilute solutions of lidocaine (0.1% or 0.05%) and epinephrine (1:1,000,000) in physiologic saline following infiltration into subcutaneous fat of liposuction surgery patients. Plasma lidocaine concentrations were measured repeatedly over more than 24 hours following the infiltration. Peak plasma lidocaine levels occurred 12–14 hours after beginning the infiltration. Clinical local anesthesia is apparent for up to 18 hours, obviating the need for postoperative analgesia. Dilution of lidocaine diminishes and delays the peak plasma lidocaine concentrations, thereby reducing potential toxicity. Liposuction reduces the total amount of lidocaine absorbed systemically, but does not dramatically reduce peak plasma lidocaine levels. A safe upper limit for lidocaine dosage using the tumescent technique is estimated to be 35 mg/kg. Infiltrating a large volume of dilute epinephrine assures diffusion throughout the entire targeted area while avoiding tachycardia and hypertension. The associated vasoconstriction is so complete that there is virtually no blood loss with liposuction. The tumescent technique can be used with general anesthesia or IV sedation. However, with appropriate instrumentation and surgical method, the tumescent technique permits liposuction of large volumes of fat totally by local anesthesia, without IV sedation or narcotic analgesia. 1990 American Society for Dermatologic Surgery, Inc.
引用
收藏
页码:248 / 263
页数:16
相关论文
共 80 条
[1]  
ADRIANI J, 1960, CLIN PHARMACOL THER, V1, P645
[2]   CARDIAC-ARREST FOLLOWING REGIONAL ANESTHESIA WITH ETIDOCAINE OR BUPIVACAINE [J].
ALBRIGHT, GA .
ANESTHESIOLOGY, 1979, 51 (04) :285-287
[3]   TOXICITY OF LOCAL-ANESTHETICS [J].
ALPER, MH .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (25) :1432-1433
[4]  
APOSTOL TM, 1967, CALCULUS, V1, P2
[5]  
ASKEN S, 1988, LIPOSUCTION SURG AUT, P63
[6]  
BARTLETT EE, 1961, ANESTH ANALG, V40, P296
[7]  
BASHEIN G, 1980, NEW ENGL J MED, V302, P122
[8]  
Benowitz N L, 1974, Cardiovasc Clin, V6, P77
[9]   CLINICAL PHARMACOKINETICS OF LIGNOCAINE [J].
BENOWITZ, NL ;
MEISTER, W .
CLINICAL PHARMACOKINETICS, 1978, 3 (03) :177-201
[10]   EFFECT OF MIDAZOLAM AND DIAZEPAM PREMEDICATION ON CENTRAL NERVOUS-SYSTEM AND CARDIOVASCULAR TOXICITY OF BUPIVACAINE IN PIGS [J].
BERNARDS, CM ;
CARPENTER, RL ;
RUPP, SM ;
BROWN, DL ;
MORSE, BV ;
MORELL, RC ;
THOMPSON, GE .
ANESTHESIOLOGY, 1989, 70 (02) :318-323